换一批
换一批Standardization of surgical and pathologic variables is needed in multicenter trials of adjuvant therapy for pancreatic cancer: results from the ACOSOG Z5031 trial.
第一作者：
Matthew H G,Katz
第一单位：
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. mhgkatz@mdanderson.org
作者：
主题词
腺癌(Adenocarcinoma);抗肿瘤药(Antineoplastic Agents);化学疗法, 辅助(Chemotherapy, Adjuvant);综合疗法(Combined Modality Therapy);人类(Humans);多中心研究(主题)(Multicenter Studies as Topic);肿瘤复发, 局部(Neoplasm Recurrence, Local);肿瘤分期(Neoplasm Staging);胰腺肿瘤(Pancreatic Neoplasms);胰十二指肠切除术(Pancreaticoduodenectomy);参考标准(Reference Standards);存活率(Survival Rate);治疗结果(Treatment Outcome)
DOI
10.1245/s10434-010-1282-y
PMID
20811779
发布时间
2024-11-26
- 浏览2
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
